Literature DB >> 2115030

Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.

J C Liu1, G A Peyman, M Oncel.   

Abstract

Suprachoroidal hemorrhages were created in 15 albino rabbit eyes by injecting 0.1 cc of autologous blood into the suprachoroidal space. One day later, 10 of these eyes were treated with intravenous tissue plasminogen activator (TPA). Doses of 1 mg per kg were given to each rabbit over 2 to 3 hours by intravenous infusion. Five eyes served as control. The rate of clearance of hemorrhage was compared in the two groups. Average day of clearance was 14 days for the treated group, and 20.2 for the untreated control group. In this study, TPA given intravenously appears to accelerate the clearance of suprachoroidal hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115030     DOI: 10.1007/bf00159862

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  15 in total

1.  Coronary thrombolysis with tissue-type plasminogen activator (t-PA): emerging strategies.

Authors:  B E Sobel
Journal:  J Am Coll Cardiol       Date:  1986-11       Impact factor: 24.094

Review 2.  Activation of the fibrinolytic system.

Authors:  A K Robison; D Collen
Journal:  Cardiol Clin       Date:  1987-02       Impact factor: 2.213

3.  Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.

Authors:  D O Williams; J Borer; E Braunwald; J H Chesebro; L S Cohen; J Dalen; H T Dodge; C K Francis; G Knatterud; P Ludbrook
Journal:  Circulation       Date:  1986-02       Impact factor: 29.690

4.  Use of tissue plasminogen activator in experimental hyphema.

Authors:  F H Lambrou; R W Snyder; G A Williams
Journal:  Arch Ophthalmol       Date:  1987-07

5.  Delayed nonexpulsive suprachoroidal hemorrhage after trabeculectomy.

Authors:  M L Ariano; S F Ball
Journal:  Ophthalmic Surg       Date:  1987-09

Review 6.  Coronary thrombolysis with tissue-type plasminogen activator.

Authors:  S R Bergmann; P A Ludbrook; B E Sobel
Journal:  Cardiol Clin       Date:  1987-02       Impact factor: 2.213

7.  Postoperative suprachoroidal hemorrhage following filtration procedures.

Authors:  J M Ruderman; T S Harbin; D G Campbell
Journal:  Arch Ophthalmol       Date:  1986-02

8.  Delayed nonexpulsive suprachoroidal hemorrhage.

Authors:  M G Gressel; R K Parrish; D K Heuer
Journal:  Arch Ophthalmol       Date:  1984-12

9.  Suprachoroidal hemorrhage after glaucoma filtering surgery.

Authors:  K Givens; M B Shields
Journal:  Am J Ophthalmol       Date:  1987-05-15       Impact factor: 5.258

10.  Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.

Authors:  A K Rao; C Pratt; A Berke; A Jaffe; I Ockene; T L Schreiber; W R Bell; G Knatterud; T L Robertson; M L Terrin
Journal:  J Am Coll Cardiol       Date:  1988-01       Impact factor: 24.094

View more
  2 in total

1.  Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage.

Authors:  Nancy Kunjukunju; Christine R Gonzales; William S Rodden
Journal:  Clin Ophthalmol       Date:  2011-02-04

2.  Modified posterior drainage of post-operative suprachoroidal hemorrhage.

Authors:  Subhendu Kumar Boral; Deepak Agarwal
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.